cercosporamide has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bazin, MA; Bodero, L; Marchand, P; Roussakis, C; Rousseau, B; Tomasoni, C | 1 |
Dowless, MS; Dumstorf, CA; Ellis, KE; Furic, L; Graff, JR; Iversen, PW; Konicek, BW; McCann, DJ; McNulty, AM; Parsons, S; Peery, RB; Pelletier, J; Robichaud, N; Sonenberg, N; Stancato, LF; Stephens, JR; Yingling, JM | 1 |
2 other study(ies) available for cercosporamide and Lung Neoplasms
Article | Year |
---|---|
Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.
Topics: Antineoplastic Agents; Benzofurans; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Molecular Structure; Structure-Activity Relationship | 2013 |
Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
Topics: Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Benzofurans; Blotting, Western; Cell Proliferation; Eukaryotic Initiation Factor-4E; Female; Humans; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Metastasis; Phosphorylation; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2011 |